Free tool
Stocks far below their 52-week high
We cover 95 companies trading at least 50% below their own 52-week high. The median market value in the group is $292.44M. Across the group, the median move over the past trading day is −0.38%. 9% of the 95 with a 200-day average trade above it. Price change over the past year runs from −64.4% to +47.0% across the middle 80 percent of the group, with a median of −37.8%.
Other lists in this group
Table
95 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +15.50% | Nov 5, 2026 |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.87B | Small cap | −28.63% | Nov 4, 2026 |
| INSP | Inspire Medical Systems, Inc. | $1.79B | Small cap | −33.04% | Nov 2, 2026 |
| ATEC | Alphatec Holdings, Inc. | $1.45B | Small cap | −41.78% | Oct 29, 2026 |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.82% | Nov 5, 2026 |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −40.82% | Nov 12, 2026 |
| PRCT | PROCEPT BioRobotics Corporation | $1.21B | Small cap | −48.36% | Nov 4, 2026 |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −48.12% | Nov 9, 2026 |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% | Nov 5, 2026 |
| ARDX | Ardelyx, Inc. | $975.95M | Small cap | −38.13% | Oct 29, 2026 |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% | Nov 9, 2026 |
| AHCO | AdaptHealth Corp. | $771.43M | Small cap | −38.44% | Nov 3, 2026 |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% | Nov 5, 2026 |
| OCS | Oculis Holding AG | $720.20M | Small cap | −25.14% | Nov 5, 2026 |
| PHR | Phreesia, Inc. | $716.58M | Small cap | −63.74% | Sep 2, 2026 |
| SSII | SS Innovations International, Inc. | $715.38M | Small cap | −50.55% | Oct 27, 2026 |
| PHAT | Phathom Pharmaceuticals, Inc. | $709.50M | Small cap | −29.50% | Oct 29, 2026 |
| ALLO | Allogene Therapeutics, Inc. | $704.80M | Small cap | +75.86% | Nov 5, 2026 |
| EVT.DE | Evotec SE | $694.87M | Small cap | −45.75% | Nov 5, 2026 |
| PROK | ProKidney Corp. | $694.58M | Small cap | −30.12% | Nov 9, 2026 |
| EVO | Evotec SE | $693.01M | Small cap | −44.13% | Nov 5, 2026 |
| TLRY.TO | Tilray Brands, Inc. | $640.36M | Small cap | +240.00% | Oct 8, 2026 |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% | Oct 8, 2026 |
| ALT | Altimmune, Inc. | $604.95M | Small cap | −14.17% | Nov 5, 2026 |
| MPLT | MapLight Therapeutics, Inc. | $596.42M | Small cap | −29.88% | Nov 12, 2026 |
| SPRY | ARS Pharmaceuticals, Inc. | $568.84M | Small cap | −55.13% | Nov 10, 2026 |
| EVH | Evolent Health, Inc. | $556.25M | Small cap | −48.86% | Nov 5, 2026 |
| DNA | Ginkgo Bioworks Holdings, Inc. | $507.75M | Small cap | −41.46% | Nov 5, 2026 |
| EVMN | Evommune, Inc. | $500.47M | Small cap | −30.25% | Nov 16, 2026 |
| 4592.T | SanBio Company Limited | $495.75M | Small cap | −57.08% | Sep 14, 2026 |
| CGC | Canopy Growth Corporation | $492.21M | Small cap | −31.46% | Nov 6, 2026 |
| WEED.TO | Canopy Growth Corporation | $489.98M | Small cap | −31.25% | Nov 6, 2026 |
| RZLT | Rezolute, Inc. | $485.31M | Small cap | −30.00% | Sep 16, 2026 |
| CAPR | Capricor Therapeutics, Inc. | $481.97M | Small cap | +49.76% | Nov 10, 2026 |
| BIOA | BioAge Labs, Inc. | $451.63M | Small cap | +107.59% | Nov 5, 2026 |
| CMPX | Compass Therapeutics, Inc. | $437.61M | Small cap | −25.91% | Nov 5, 2026 |
| EYPT | EyePoint, Inc. | $430.20M | Small cap | −57.85% | Nov 4, 2026 |
| LXEO | Lexeo Therapeutics, Inc. | $420.90M | Small cap | +3.30% | Nov 4, 2026 |
| UPB | Upstream Bio, Inc. | $390.52M | Small cap | −57.31% | Nov 4, 2026 |
| LYEL | Lyell Immunopharma, Inc. | $362.68M | Small cap | +37.32% | Nov 6, 2026 |
| EBS | Emergent BioSolutions Inc. | $306.10M | Small cap | −30.50% | Oct 28, 2026 |
| BCYC | Bicycle Therapeutics plc | $304.03M | Small cap | −37.79% | Oct 29, 2026 |
| AVXL | Anavex Life Sciences Corp. | $300.34M | Small cap | −65.71% | Nov 24, 2026 |
| MYGN | Myriad Genetics, Inc. | $298.43M | Small cap | −47.39% | Nov 2, 2026 |
| TRDA | Entrada Therapeutics, Inc. | $296.70M | Small cap | +23.24% | Nov 5, 2026 |
| FULC | Fulcrum Therapeutics, Inc. | $294.51M | Small cap | −41.78% | Oct 29, 2026 |
| NMRA | Neumora Therapeutics, Inc. | $293.12M | Small cap | −11.36% | Nov 5, 2026 |
| TTRX | Turn Therapeutics Inc. | $292.44M | Small cap | +37.57% | Nov 12, 2026 |
| CV | CapsoVision, Inc. | $291.27M | Small cap | +46.97% | Nov 12, 2026 |
| EMBC | Embecta Corp. | $285.00M | Small cap | −64.70% | Nov 25, 2026 |
| SION | Sionna Therapeutics, Inc. | $282.58M | Small cap | −75.45% | Nov 5, 2026 |
| SUS.ST | Surgical Science Sweden AB (publ) | $279.10M | Small cap | −48.69% | Nov 12, 2026 |
| IVVD | Invivyd, Inc. | $265.78M | Small cap | +3.52% | Nov 5, 2026 |
| RXST | RxSight, Inc. | $265.36M | Small cap | −25.38% | Nov 4, 2026 |
| NAGE | Niagen Bioscience, Inc. | $260.44M | Small cap | −66.22% | Nov 3, 2026 |
| LAB | Standard BioTools Inc. | $255.18M | Small cap | −49.08% | Nov 3, 2026 |
| AKBA | Akebia Therapeutics, Inc. | $251.20M | Small cap | −69.88% | Nov 9, 2026 |
| PEPG | PepGen Inc. | $237.21M | Small cap | +159.68% | Nov 11, 2026 |
| TNXP | Tonix Pharmaceuticals Holding Corp. Common Stock | $233.94M | Small cap | −57.61% | Nov 9, 2026 |
| TARA | Protara Therapeutics, Inc. | $231.06M | Small cap | +21.05% | Nov 10, 2026 |
| TSND.TO | TerrAscend Corp. | $228.23M | Small cap | −44.44% | Nov 12, 2026 |
| ORGO | Organogenesis Holdings Inc. | $225.18M | Small cap | −63.84% | Nov 5, 2026 |
| NGEN | NervGen Pharma Corp. | $223.65M | Small cap | −8.30% | Nov 23, 2026 |
| SIGA | SIGA Technologies, Inc. | $220.58M | Small cap | −57.93% | Nov 5, 2026 |
| KROS | Keros Therapeutics, Inc. | $220.48M | Small cap | −28.35% | Nov 4, 2026 |
| ARMP | Armata Pharmaceuticals, Inc. | $202.64M | Small cap | +123.36% | Nov 11, 2026 |
| KRRO | Korro Bio, Inc. | $201.45M | Small cap | −36.61% | Nov 12, 2026 |
| AIRS | AirSculpt Technologies, Inc. | $196.10M | Small cap | −57.30% | Nov 9, 2026 |
| HUMA | Humacyte, Inc. | $189.35M | Small cap | −55.45% | Nov 12, 2026 |
| AIDX.TO | Healwell AI Inc. | $189.11M | Small cap | −40.08% | Nov 5, 2026 |
| WW | WW International, Inc. | $175.98M | Small cap | −45.96% | Nov 5, 2026 |
| QSI | Quantum-Si incorporated | $173.05M | Small cap | −31.84% | Nov 5, 2026 |
| NYXH | Nyxoah SA | $164.12M | Small cap | −73.74% | Nov 5, 2026 |
| LFMD | LifeMD, Inc. | $156.17M | Small cap | −49.45% | Nov 9, 2026 |
| TNYA | Tenaya Therapeutics, Inc. | $156.11M | Small cap | −36.71% | Nov 11, 2026 |
| OWLT | Owlet, Inc. | $150.78M | Small cap | −28.43% | Nov 12, 2026 |
| AARD | Aardvark Therapeutics, Inc. | $149.04M | Small cap | −24.25% | Nov 12, 2026 |
| KRMD | KORU Medical Systems, Inc. | $148.21M | Small cap | −24.47% | Nov 11, 2026 |
| MIST | Milestone Pharmaceuticals Inc. | $146.91M | Small cap | −33.33% | Nov 12, 2026 |
| LENZ | LENZ Therapeutics, Inc. | $146.73M | Small cap | −87.21% | Nov 4, 2026 |
| OPRX | OptimizeRx Corporation | $145.98M | Small cap | −55.79% | Nov 5, 2026 |
| STXS | Stereotaxis, Inc. | $145.29M | Small cap | −49.48% | Nov 16, 2026 |
| INO | Inovio Pharmaceuticals, Inc. | $134.42M | Small cap | −47.15% | Nov 10, 2026 |
| ADCT | ADC Therapeutics SA | $134.05M | Small cap | −67.39% | Nov 10, 2026 |
| ENGN | enGene Therapeutics Inc. | $130.63M | Small cap | −55.07% | Sep 14, 2026 |
| BDTX | Black Diamond Therapeutics, Inc. | $130.42M | Small cap | −20.91% | Nov 5, 2026 |
| CBUS | Cibus, Inc. | $128.40M | Small cap | +27.27% | Nov 12, 2026 |
| QTRX | Quanterix Corporation | $126.75M | Small cap | −41.87% | Nov 9, 2026 |
| GUTS | Fractyl Health, Inc. | $124.77M | Small cap | −25.55% | Nov 11, 2026 |
| NTHI | NeOnc Technologies Holdings, Inc. | $122.16M | Small cap | −29.30% | Nov 12, 2026 |
| HCAT | Health Catalyst, Inc. | $118.91M | Small cap | −56.91% | Nov 9, 2026 |
| RANI | Rani Therapeutics Holdings, Inc. | $118.23M | Small cap | +49.45% | Nov 5, 2026 |
| NAUT | Nautilus Biotechnology, Inc. | $111.99M | Small cap | +33.34% | Oct 27, 2026 |
| HBP.TO | Helix BioPharma Corp. | $106.76M | Small cap | +46.97% | Oct 29, 2026 |
| DVYSR.ST | Devyser Diagnostics AB (publ) | $105.23M | Small cap | −60.78% | Nov 3, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.